Sinofn Health
Doha’s Healthcare Evolution: As Qatar moves towards the National Vision 2030, the healthcare landscape in Doha is witnessing a shift towards preventative and specialized nutrition. With a rising prevalence of metabolic disorders and lifestyle-related health challenges, there is a critical requirement for Foods for Special Medical Purposes (FSMP). SINOFN stands at the forefront of this transformation, offering scientifically backed nutritional solutions tailored for the Middle Eastern medical market.
Our manufacturing capabilities integrate Chinese industrial efficiency with international regulatory standards. By leveraging partnerships with the Chinese Academy of Sciences and adhering to FSSC 22000, HACCP, and Halal certification protocols, SINOFN ensures that our FSMP products are not only compliant with local Gulf standards but also optimized for bioavailability and efficacy.
We are currently investing in "Personalized Clinical Nutrition," using big data to analyze nutrient gaps in the Doha population. Our R&D team, led by Dr. Tan Shengjie and Dr. Zhang Ying, is pioneering delivery systems that enhance patient adherence to dietary restrictions, particularly in PKU management and geriatrics.
Chinese factories like SINOFN offer a unique blend of high-end R&D, cost-efficient scaling, and rigorous compliance. We provide "Information Gain" to our partners by sharing proprietary stability data and clinical research, ensuring your products exceed the expectations of Middle Eastern healthcare regulators.
Our quality management systems are specifically designed for global export. We work closely with Halal certification bodies to ensure all raw materials, including gelatin and excipients, meet Sharia compliance standards, facilitating smooth entry into the Qatari market.
With our Tianjin R&D center, we offer pilot-scale production lines that allow brands to test market viability in Doha with lower MOQs before committing to full-scale mass production.